Philip Morris International (PMI), the international tobacco giant responsible for producing Marlboro cigarettes, is approaching the reaching of a £1 billion deal to acquire UK inhaler company Ventura.
Directors at the respiratory health care company have recommended to shareholders that they accept the tobacco maker’s offer.
It comes after a broad group of leading health charities, public health experts and doctors sent a letter to the board calling for them to reject the bid.
The proposed takeover now requires the approval of shareholders holding at least a 50 per cent ownership stake in the company.
Although PMI has repeatedly stated its intention to withdraw from the cigarette market, the vast majority of its revenue comes from selling cigarettes and other ‘combustible’ tobacco products.
As such, health groups have warned that the deal would significantly damage the future prospects of the healthcare company, pushing staff and researchers away.
From a fiscal perspective at least though, it seems the potential deal is working wonders for Ventura, with share values soaring more than a third since May.
Thinking of housing as part of an urban system: what Malta can learn from Singapore’s public housing
Five lessons we can take from the nation twice the size of Malta
Ryanair cuts Malta link to Serbia’s Niš
The low-cost airline is slashing some major routes in Germany, Spain, Belgium, Portugal and Malta
Event tourism is the standout travel trend for 2026 – How will Malta fare?
The global tourism market is booming, and events are leading the way